ValerieCurren (@ValerieCurren)

About 20 percent of patients given the medicine, oseltamivir — sold both as a generic and under the name Tamiflu — died over the next 90 days, the researchers reported. Oseltamivir proved so deadly the researchers stopped its use in the trial early. “Treatment with oseltamivir is ineffective and highly likely to increase 90-day mortality in critically ill patients with influenza,” they wrote bluntly in a 29-page “preprint” released in late July. https://alexberenson.substack.com/p/urgent-tamiflu-kills